Global Human Chorionic Gonadotropin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

  • ID: 3952459
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4
The Human Chorionic Gonadotropin Market Was Estimated at USD 346.3 Mn in 2015, and Is Required to Achieve USD 533.7Mn by 2022

FEATURED COMPANIES

  • Emd Serono, Inc.
  • Ferring B.V.
  • Fresenius Kabi Usa, Llc
  • Merck & Co., Inc.
  • MORE

Infertility treatment in both guys and females is the significant treatment territory where HCG is usually managed. Developing rate of fruitlessness in ladies, contributed by expanded maternity age, way of life impacts and others, hormonal dysfunctions in men and developing occurrence of oligospermia are the key elements that have bolstered the interest for HCG sedates in the market. The interest for HCG is unfaltering in created markets of Europe and North America. Then again, developing mindfulness as a rule populace and improvement of medicinal services framework are supporting the development sought after for HCG medicates in developing markets.

HCG bolsters the typical advancement of egg in ovary and invigorates egg discharge amid ovulation. It is likewise utilized for fruitlessness treatment as a part of ladies and to enlarge sperm number in men. Young men with undescended gonads are likewise regulated HCG treatment. Hugh commonness of both male and female Infertility issues, extending occurrence of low sperm include and sperm thickness men are is the key variable driving the HCG drugs market. A larger part of the items as of now accessible in the market are characteristic source, i.e. pee inferred HCG. In any case, in perspective of cluster to group irregularity in item immaculateness and prerequisite of vast measure of pee has brought about rise of recombinant creation innovation.

North America is relied upon to be the biggest and most potential local market for human chorionic gonadotropin. North America constitutes territorial markets of U.S. what's more, Canada, the rising frequency of fruitlessness cases, way of life impacts and others, hormonal dysfunctions in men and ladies are the real driver for the development of the worldwide human chorionic gonadotropin market. Asia-Pacific is the normal to bethe most potential provincial market for human chorionic gonadotropin market by2022. Throughout the following six years, the development of the market in the Asia-Pacific area is probably going to be focused in Japan, South Korea, China, and India.The enter players in human chorionic gonadotropin market are EMD Serono, Inc.,Ferring B.V., Merck and Co., Inc., Bristol Myers Squibb Company and Fresenius KabiUSA, LLC.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Emd Serono, Inc.
  • Ferring B.V.
  • Fresenius Kabi Usa, Llc
  • Merck & Co., Inc.
  • MORE

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose Of The Report
1.1.2 Target Audience
1.1.3 Usp And Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase Ii – Primary Research
1.3.3 Phase Iii – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Human Chorionic Gonadotropin Market, By Therapeutic Area, 2015 (USD MN)
2.2 Global Human Chorionic Gonadotropin Market, By Technology, 2015 (USD MN)
2.3 Global Human Chorionic Gonadotropin Market, By Therapeutic Area Market, By Geography, 2015 (Value %)

Chapter 3 Global Hematopoietic Stem Cells Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 High Infertility Prevalence Worldwide
3.3 Market Restraints
3.3.1 Availability Of Substitutes
3.4 Market Opportunities
3.4.1 Demand For Recombinant HCG
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Human Chorionic Gonadotropin Market, By Key Players

Chapter 4 Global Human Chorionic Gonadotropin Market Analysis, By Treatment
4.1 Overview
4.2 Female Infertility Treatment
4.3 Oligospermia Treatment
4.4 Cryptorchidism Treatment
4.5 Others

Chapter 5 Global Human Chorionic Gonadotropin Market Analysis, By Technology
5.1 Overview
5.2 Natural Source Extraction
5.3 Recombinant Dna Technology

Chapter 6 Global Human Chorionic Gonadotropin Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East And Africa

Chapter 7 Company Profiles
7.1 Ferring B.V.
7.1.1 Ferring B.V.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Bristol Mayer Squibb Company
7.2.1 Bristol Mayer Squibb Company: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 Emd Serono, Inc.
7.3.1 Emd Serono, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresenius Kabi Usa, Llc
7.4.1 Fresenius Kabi Usa, Llc: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)

Fig. 1 Human Chorionic Gonadotropin Market: Research Methodology
Fig. 2 Global Human Chorionic Gonadotropin Market, By Therapeutic Area, 2015 (USD MN)
Fig. 3 Global Human Chorionic Gonadotropin Market, By Technology, 2015 V/S 2022 (Value %)
Fig. 4 Global Human Chorionic Gonadotropin Market, By Geography, 2015 (Value %)
Fig. 5 Attractive Investment Proposition, By Geography, 2015
Fig. 6 HCG Market In Female Infertility Treatment, 2014 – 2022 (USD MN)
Fig. 7 HCG Market In Oligospermia Treatment, 2014 – 2022 (USD MN)
Fig. 8 HCG Market In Cryptorchidism Treatment, 2014 – 2022 (USD MN)
Fig. 9 HCG Market In Other Treatments, 2014 – 2022 (USD MN)
Fig. 10 HCG From Natural Source Extraction Market, 2014 – 2022 (USD MN)
Fig. 11 HCG From Recombinant Dna Technology Market, 2014 – 2022 (USD MN)
Fig. 12 North America Human Chorionic Gonadotropin Market, By Country, 2013 – 2022 (USD MN)
Fig. 13 Europe Hematopoietic Stem Cell Transplant Market , 2013 – 2022 (USD MN)
Fig. 14 Asia-Pacific Human Chorionic Gonadotropin Market , 2013 – 2022 (USD MN)
Fig. 15 Latin America Human Chorionic Gonadotropin Market, 2016 – 2022 (USD MN)
Fig. 16 Middle East And Africa Human Chorionic Gonadotropin Market, 2016 – 2022 (USD MN)

Table 1 Therapeutics Category
Table 2 Market Competition Assessment: Human Chorionic Gonadotropin Products, By Key Players
Table 3 Global Human Chorionic Gonadotropin Market, By Treatment, 2014-2022 (USD MN)
Table 4 Global Human Chorionic Gonadotropin Market, By Technology, 2014-2022 (USD MN)
Table 5 Global Human Chorionic Gonadotropin Market, By Geography, 2016 – 2022 (USD MN)
Table 6 Ferring B.V.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 7 Bristol Mayer Squibb Company: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 8 Emd Serono, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 9 Fresenius Kabi Usa, Llc: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 10 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

Bristol Mayer Squibb Company
Emd Serono, Inc.
Ferring B.V.
Fresenius Kabi Usa, Llc
Merck & Co., Inc.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll